Pancreatic Cancer Research

ResearcherHubei University of TechnologyActive in the last 2 years

Jingfeng Tang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5524-4518; OpenAlex author ID A5040694417. Sources: OpenAlex.

Their work

Papers
13 (first author 0, last author 8)
Trials
0
Grants
0
Labs led
1
Collaborators
15
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 2 papers · 2025: 3 papers · 2026: 4 papers

Papers 13

  1. Phosphorylated STYK1 Promotes Gemcitabine Resistance via Autophagy-Mediated Cancer Stemness in Pancreatic Cancer. Last author DOI 10.1002/advs.202521488↗
  2. KRAS Inhibitor Resistance Confers a Targetable Vulnerability to Ferroptosis in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/0008-5472.can-26-1490↗
  3. tRNA m2G methyltransferase complex THUMPD3-TRMT112 promotes pancreatic cancer progression and autophagy via modulating TFEB translation. Last author DOI 10.1186/s12943-025-02540-2↗
  4. Decoding Drug Resistance in Pancreatic Cancer: A Subcellular Structure Perspective. Co-author DOI 10.3390/biology15070574↗
  5. Long non-coding RNAs: Emerging regulators of invasion and metastasis in pancreatic cancer. Co-author DOI 10.1016/j.jare.2025.02.001↗
  6. Lactate Metabolism: The String-Puller for the Development of Pancreatic Cancer. Last author DOI 10.3390/biology14091213↗
  7. Emerging non-invasive imaging biomarkers of Ki-67 in pancreatic cancer: Toward predictive precision oncology. Co-author DOI 10.4251/wjgo.v17.i11.110468↗
  8. The Emerging Scenario of Ferroptosis in Pancreatic Cancer Tumorigenesis and Treatment. Co-author DOI 10.3390/ijms252413334↗
  9. LncRNAs as nodes for the cross-talk between autophagy and Wnt signaling in pancreatic cancer drug resistance. Last author DOI 10.7150/ijbs.91832↗
  10. Identification of Wnt/β-Catenin- and Autophagy-Related lncRNA Signature for Predicting Immune Efficacy in Pancreatic Adenocarcinoma. Last author DOI 10.3390/biology12020319↗
  11. The LCK-14-3-3ζ-TRPM8 axis regulates TRPM8 function/assembly and promotes pancreatic cancer malignancy. Last author DOI 10.1038/s41419-022-04977-5↗
  12. TSPAN1 promotes autophagy flux and mediates cooperation between WNT-CTNNB1 signaling and autophagy via the MIR454-FAM83A-TSPAN1 axis in pancreatic cancer. Last author DOI 10.1080/15548627.2020.1826689↗
  13. LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modulating the miR-619-5p/Pygo2 and… Last author DOI 10.1186/s12943-020-01237-y↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Cefan Zhou · 12 shared papers, 2020–2026 · strength 2.51
  2. Hao Lyu · 7 shared papers, 2023–2026 · strength 1.61
  3. Yuan Huang · 4 shared papers, 2020–2023 · strength 0.52
  4. Rui Zhang · 3 shared papers, 2020–2024 · strength 0.50
  5. Yixin Wu · 1 shared paper, 2025 · strength 0.30
  6. Xiaowen Li · 1 shared paper, 2026 · strength 0.27
  7. Ying Zhao · 1 shared paper, 2026 · strength 0.26
  8. Sihan Huo · 1 shared paper, 2026 · strength 0.26
  9. Minghe Fan · 1 shared paper, 2026 · strength 0.26
  10. Lan Yang · 1 shared paper, 2025 · strength 0.26
  11. Mengmeng Shi · 1 shared paper, 2025 · strength 0.26
  12. Wenbin Yuan · 1 shared paper, 2026 · strength 0.24
  13. Yu-Han Huang · 1 shared paper, 2024 · strength 0.23
  14. Xueying Dong · 1 shared paper, 2026 · strength 0.22
  15. Xuewen Zhang · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.